ARDD 2026 description: Wei-Wu He on a genome-to-digital-twin longevity cohort
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →At a glance
Automatic summary · not editorially reviewedThe description says Wei-Wu He of Human Longevity, Inc. presented at ARDD 2026 on a Human Longevity Longitudinal Cohort combining whole-genome sequencing with AI, which the creator says may enable earlier disease prediction and prevention and potentially push average life expectancy toward 100. [1]
The description attributes an ARDD 2026 presentation by Wei-Wu He of Human Longevity, Inc. on a Human Longevity Longitudinal Cohort going from genome to a digital health twin. [1]
The creator's key takeaway says whole-genome sequencing plus AI enables earlier prediction and prevention of disease, potentially pushing average life expectancy toward 100. [1]
The description says ARDD made its North American debut in Boston at Harvard University on October 1-3, 2026, organized by Insilico Medicine with support from many listed organizations. [1]
He's genome-to-digital-twin cohort talk at ARDD 2026
The description attributes a presentation to Wei-Wu He of Human Longevity, Inc. at the 13th Aging Research and Drug Discovery Meeting. The stated title links a Human Longevity Longitudinal Cohort with a path from genome to a digital health twin, framed as building precision longevity. These are the creator's characterizations of the talk; the description gives no cohort size, follow-up period or measured outcomes. [1]
Creator's takeaway: sequencing plus AI for earlier prediction
As the key takeaway, the description states that whole-genome sequencing plus AI enables earlier prediction and prevention of disease, potentially pushing average life expectancy toward 100. This is presented as a potential, not a demonstrated result: the description reports no study design, comparison group, effect size or uncertainty for that expectation. [1]
Conference context and sponsors named in the description
The description says ARDD was founded by Alex Zhavoronkov in 2014 and made its North American debut in Boston at Harvard University on October 1-3, 2026, opened by a ribbon-cutting led by Admiral Brian Christine, US Assistant Secretary for Health. It lists Insilico Medicine as organizer with support from many companies and organizations, including Human Longevity. These are event details, not findings about health outcomes. [1]
Context & limits
This is based only on the supplied video description; the video and transcript were not reviewed. The description gives no cohort size, follow-up, study design, comparator or measured outcomes, and the life-expectancy expectation is the creator's potential claim, not a demonstrated result.
Based on the creator’s description; the full video and transcript were not analyzed.
Quoted passages in the original language
Human Longevity Longitudinal Cohort: From Genome to
potentially pushing average life expectancy toward 100
ARDD made its North American debut in
About this video
Creator description · original textText language: English
ARDD · 23 min · Source published: 2026-10-20
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.